on 12 Oct 2022
Last Applicant/ Owned by
NEOMORPH INC.
780 Third Ave., 37th FloorNew York NY 10017
US
Serial Number
2087315 filed on 8th Jan 2021
Registration Number
TMA1146024 registered on 12th Oct 2022
Registration expiry Date
8th Jan 2031Trademark usage description
research and development in the field of small molecule therapeutics; research and development in the field of targeted protein degrader drugs; pharma Read MoreVienna Information
26 . 4 . 4
Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis
26 . 4 . 9
Several quadrilaterals juxtaposed, joined or intersectingPlusieurs quadrilatères, juxtaposés, accolés ou se coupant
26 . 4 . 24
Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée
26 . 13 . 25
Other geometrical figures, indefinable designs -- Note: Including scratch marks.Autres figures géométriques, dessins indéfinissables -- Note: Y compris les marques de griffes.
27 . 5 . 1
Letters presenting a special form of writingLettres présentant un graphisme spécial
27 . 5 . 21
One letterUne lettre
11
2087315
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 222 on 18th Jul 2022 | Opposition Start Date Notice Sent |
Submitted for opposition 26 on 24th Jun 2022 | Approved |
Submitted for opposition 27 on 24th Jun 2022 | Approval Notice Sent |
Submitted for opposition 22 on 20th Jun 2022 | Search Recorded |
Submitted for opposition 256 on 27th Dec 2021 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 25th Feb 2021 | Designation Notification - Madrid Protocol |
Submitted for opposition 31 on 24th Feb 2021 | Formalized |
Submitted for opposition 1 on 24th Feb 2021 | Created |
Submitted for opposition 228 on 8th Jan 2021 | International Registration |
Submitted for opposition 30 on 8th Jan 2021 | Filed |